Microbot Medical Inc. (MBOT) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 2 Buy, 1 Hold.
The consensus price target is $5.50, representing an upside of 126.3% from the current price $2.43.
Analysts estimate Earnings Per Share (EPS) of $-0.71 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.01 vs est $-0.71 (beat +101.6%). 2025: actual $-0.29 vs est $-0.30 (beat +3.3%). Analyst accuracy: 0%.
MBOT Stock — 12-Month Price Forecast
$5.50
▲ +126.34% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Microbot Medical Inc., the price target is $5.50.
The average price target represents a +126.34% change from the last price of $2.43.
MBOT Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to Microbot Medical Inc. in the past 3 months
EPS Estimates — MBOT
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.01
vs Est –$0.71
▲ 6,220.7% off
2025
Actual –$0.29
vs Est –$0.30
▲ 3.4% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect losses to continue near-term.
Revenue Estimates — MBOT
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
